Maria Ourania Panagiotou, Rawan Elmanfalouty, Clement Moyo, Alkistis Papatheodoridi, Yostena Nagy Mekhail, Subhania Khan, Panagiotis J. Vlachostergios, Saifee Mullamitha, Jurjees Hasan, Kalena Marti, Michael Braun, Angelos Angelakas, Rachel Broadbent, Mark P. Saunders, Konstantinos Vellios Kamposioras. "Stratifying survival benefit of encorafenib/cetuximab (EC) in BRAF V600E–mutant mCRC using clinical and inflammatory biomarkers: Real-world experience from greater Manchester.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15563